Carregant...
Case of drug-induced interstitial lung disease secondary to adalimumab
We report a rare case of drug-induced intestinal lung disease (ILD) secondary to adalimumab, a tumour necrosis factor alpha-receptor blocker. A 52-year-old smoker with ankylosing spondylitis, treated with adalimumab, presented with progressive breathlessness. A high resolution CT chest demonstrated...
Guardat en:
| Publicat a: | BMJ Case Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5965751/ https://ncbi.nlm.nih.gov/pubmed/29764848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-224375 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|